Status:
COMPLETED
Typology of Adherence in Adolescents: Phase II
Lead Sponsor:
University of North Carolina, Chapel Hill
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
National Institute of Mental Health (NIMH)
Conditions:
HIV Infection
Eligibility:
All Genders
12-24 years
Brief Summary
A number of factors influence HIV-positive adolescents' acceptance of and willingness to continue taking anti-HIV medicines. These factors include mental health and substance abuse issues, barriers su...
Detailed Description
As more HIV-infected adolescents are identified and linked into care, the dyad of medication and medication adherence continues to be an issue for both the provider and the patients. Thus, developing ...
Eligibility Criteria
Inclusion
- Between the ages of 12 years and 24 years
- Eligible for ART (antiretroviral therapy) based on US Public Health Service guidelines
- Have been offered and/or prescribed HAART (highly active antiretroviral therapy)
- Ability to give informed consent or assent with parental permission, where required
Exclusion
- Infected with HIV but do not require ART
- Started HAART but stopped due to medical reasons, (e.g., change in medication guidelines, toxicity, resistance, etc.)
- Females prescribed/receiving HAART for the purpose of preventing mother-to-child transmission
Key Trial Info
Start Date :
June 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2005
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT00106678
Start Date
June 1 2004
End Date
April 1 2005
Last Update
March 1 2017
Active Locations (17)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital of Los Angeles
Los Angeles, California, United States, 90027
2
University of California at San Diego
San Diego, California, United States, 92103
3
University of California at San Francisco
San Francisco, California, United States, 94143
4
Children's National Medical Center
Washington D.C., District of Columbia, United States, 20010